SCHEMBL3416288

SCHEMBL3416288

Cn1cc(-c2ccc(N)nn2)cn1.Cn1cc(-c2ccc3nccn3n2)cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 10/20 0.49
DYRK1A Q13627 3/20 0.47
FYN P06241 6/20 0.46
DYRK1B Q9Y463 3/20 0.45
JAK2 O60674 2/20 0.45
RET P07949 2/20 0.45
KDR P35968 2/20 0.45
GSK3A P49840 2/20 0.45
RPS6KA3 P51812 2/20 0.45
LIMK1 P53667 2/20 0.45
MAP2K1 Q02750 2/20 0.45
CLK4 Q9HAZ1 2/20 0.45
ALK Q9UM73 2/20 0.45
MAPK14 Q16539 1/20 0.45
GRK5 P34947 1/20 0.42
ABL1 P00519 2/20 0.41
MAPK8 P45983 2/20 0.41
AURKA O14965 1/20 0.41
DAPK3 O43293 1/20 0.41
MAP4K4 O95819 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3409540 0.89 DYRK1A (0.58) METDYRK1AFYNDYRK1BJAK2
SCHEMBL4517082 0.82 SMARCA2 (0.48) FYNKDRGRK5AURKALRRK2
SCHEMBL3410381 0.74 SMARCA2 (0.42) KDRCSF1R
SCHEMBL26176238 0.71 PRKCI (0.47) METDYRK1AFYNDYRK1BJAK2
SCHEMBL31601841 0.70 DYRK1A (0.63) DYRK1AFYNDYRK1BJAK2RET
SCHEMBL16562531 0.70 DYRK1A (0.48) METDYRK1AFYNDYRK1BJAK2
SCHEMBL19338499 0.70 FYN (0.48) METDYRK1AFYNDYRK1BGRK5
SCHEMBL25197327 0.70 LRRK2 (0.47) METROCK1LRRK2
SCHEMBL30348542 0.70 LRRK2 (0.47) METROCK1LRRK2
SCHEMBL16554646 0.69 DYRK1A (0.50) METDYRK1AFYNDYRK1BJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2265614-A1 IMIDAZO [1,2-B]PYRIDAZINE DERIVATIVES FOR THE TREATMENT OF C-MET TYROSINE KINASE MEDIATED DISEASE Novartis AG (CH) 2010-12-29 EP disclosed
WO-2009106577-A1 IMIDAZO [1,2-B] PYRIDAZINE DERIVATIVES FOR THE TREATMENT OF C-MET TYROSINE KINASE MEDIATED DISEASE NOVARTIS AG (CH) 2009-09-03 WO disclosed